MoneyWorks4Me

Ajanta Pharma informs about disclosure

03 Jul 2026 Evaluate

Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Aayush Agrawal Trust & Aayush Agrawal.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1857.05
Dr. Reddys Labs. 1170.90
Cipla 1374.85
Lupin 2087.75
Zydus Lifesciences 1133.50
View more..